KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Common Equity (2016 - 2025)

Encompass Health (EHC) has disclosed Common Equity for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 17.96% year-over-year to $2.4 billion, compared with a TTM value of $2.4 billion through Dec 2025, up 17.96%, and an annual FY2025 reading of $2.4 billion, up 17.96% over the prior year.
  • Common Equity was $2.4 billion for Q4 2025 at Encompass Health, down from $3.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $3.0 billion in Q2 2025 and bottomed at $1.2 billion in Q3 2022.
  • Average Common Equity over 5 years is $2.2 billion, with a median of $2.3 billion recorded in 2021.
  • The sharpest move saw Common Equity plummeted 46.17% in 2022, then rose 28.22% in 2023.
  • Year by year, Common Equity stood at $2.4 billion in 2021, then dropped by 22.52% to $1.8 billion in 2022, then rose by 23.48% to $2.3 billion in 2023, then fell by 8.35% to $2.1 billion in 2024, then increased by 17.96% to $2.4 billion in 2025.
  • Business Quant data shows Common Equity for EHC at $2.4 billion in Q4 2025, $3.0 billion in Q2 2025, and $2.9 billion in Q1 2025.